Immunization against ?-amyloid (A?) is pursued as a possible strategy for the prevention of Alzheimer's disease (AD). In clinical trials, A? 1-42 proved poorly immunogenic and caused severe adverse effects; therefore, safer and more immunogenic candidate vaccines are needed. Multimeric protein (1-11)E2 is able to induce an antibody response to A?, immunological memory, and IL-4 production, with no concomitant anti-A? T cell response. Antisera recognize A? oligomers, protofibrils, and fibrils. In this study, we evaluated the effect of prophylactic immunization with three doses of (1-11)E2 in alum in the 3xTg mouse model of AD. Immunization with (1-11)E2 efficiently induced anti-A? antibodies, but afforded no protection against A? accumulation and neuroinflammation. The identification of the features of the anti-A? immune response that correlate with the ability to prevent A? accumulation remains an open problem that deserves further investigation

vaccination with (1-11) E2 in alum efficiently induces an antibody response to b-amyloid and microglia activation in 3xTg mice

Mantile F;Liguori GL;Prisco A
2019

Abstract

Immunization against ?-amyloid (A?) is pursued as a possible strategy for the prevention of Alzheimer's disease (AD). In clinical trials, A? 1-42 proved poorly immunogenic and caused severe adverse effects; therefore, safer and more immunogenic candidate vaccines are needed. Multimeric protein (1-11)E2 is able to induce an antibody response to A?, immunological memory, and IL-4 production, with no concomitant anti-A? T cell response. Antisera recognize A? oligomers, protofibrils, and fibrils. In this study, we evaluated the effect of prophylactic immunization with three doses of (1-11)E2 in alum in the 3xTg mouse model of AD. Immunization with (1-11)E2 efficiently induced anti-A? antibodies, but afforded no protection against A? accumulation and neuroinflammation. The identification of the features of the anti-A? immune response that correlate with the ability to prevent A? accumulation remains an open problem that deserves further investigation
2019
Alzheimer's disease; Antibody response; Immunization; ?-amyloid.
File in questo prodotto:
Non ci sono file associati a questo prodotto.

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/20.500.14243/442837
Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus ND
  • ???jsp.display-item.citation.isi??? ND
social impact